JD.com heads into its August 13 earnings with options sentiment at its most bullish in months, even as short sellers rebuild positions after a sharp weekly rally.
The clearest signal this week is in options. The put/call ratio has dropped to 0.55 — nearly two standard deviations below its 20-day average of 0.60 — marking the most call-heavy skew JD has seen in recent history relative to that baseline. The PCR sits well clear of its 52-week low of 0.33, so this isn't extreme positioning, but the direction is unambiguous: options traders have rotated toward calls as the stock gained 8.9% over the past week to close at $28.84. That weekly move is one of the stronger prints across China e-commerce peers — BABA gained 14.4% on the week while PDD added just 1.7%, suggesting this was partly a broad China tech bid but JD held its own.
Short positioning tells a more cautious story about whether the rally has legs. Estimated short interest ticked up 9.8% in a single session on July 14 — a notable one-day rebuild — though it remains 6.4% lower than a week earlier. The borrow market stays loose: availability is at 160%, meaning roughly 1.6 shares are available to lend for every share already borrowed. Cost to borrow is a negligible 0.48%. There is no squeeze pressure here. The ORTEX short score has drifted modestly higher to 49.8 from around 47-48 earlier in the week, but sits squarely in neutral territory — shorts are repositioning, not crowding.
The Street remains broadly constructive, with some near-term trimming. Barclays cut its target from $43 to $41 today while keeping an Overweight rating — a signal of confidence tempered by valuation comfort after the run. The broader analyst cohort had lifted targets sharply following the Q1 beat in May, when JD reported RMB 301 billion in revenue, 15.8% ahead year-on-year and RMB 11 billion above consensus. That beat drives a standout EPS surprise factor score in the 94th percentile and strong 90-day EPS momentum at the 85th percentile. The tension is on profitability: net margin guidance for FY25-26 sits at just 3.9-4.0%, and the bear case centres on subsidy-driven losses per order and thin unit economics. Valuation multiples remain undemanding — the trailing PE is 6.8x and EV/EBITDA is 3.6x, both having compressed over the past 30 days as the stock drifted sideways before this week's move. The analyst mean price target of $41 implies roughly 42% upside from current levels at $28.84.
Insider activity is not a meaningful signal here. The CEO and CFO each sold small parcels — worth $30,000 and $15,000 respectively — on July 2, immediately following routine share awards the prior day. The 90-day net insider position is a near-zero $45,500 in value. Founder and Chairman Richard Liu received a 1 million share award in May, but at $0 cost that is a compensation event, not a market signal.
The last two earnings events produced opposite reactions: a 10.6% one-day rally after the Q1 May print, and a 5.2% decline after the Q4 February release. With August 13 now six weeks away, the question sharpening for positioning is whether JD can sustain the topline growth rate while showing any credible progress on the margin trajectory that analysts cut in May.
See the live data behind this article on ORTEX.
Open JD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
